Digital Monitoring

Google launches DeepMind 2, a pharmaceutical hullabaloo

Alphabet (the umbrella corp that owns Google and DeepMind) just launched Isomorphic Labs (IL). According to the new company’s blog, it’s “reimagining the entire drug discovery process from first principles with an AI-first approach.” In other words: The CEO of DeepMind, Demis Hassabis, is going to run a drug-discovery spinoff. [...]


google.com